Life Sciences

Thermo Fisher stock steadies near $504 as Danaher’s $9.9 billion Masimo deal rattles life-sciences names

Thermo Fisher stock steadies near $504 as Danaher’s $9.9 billion Masimo deal rattles life-sciences names

Thermo Fisher shares dipped $0.43 to $504.39 Tuesday afternoon, little changed despite renewed deal activity in the sector. The company recently priced $3.8 billion in debt to fund its $8.9 billion Clario acquisition, with shares down about 6% since last week. Danaher fell 3.4% after agreeing to buy Masimo for $9.9 billion. Investors await Agilent’s Feb. 25 results and Thermo Fisher’s April 22 earnings.
February 17, 2026

Stock Market Today

  • Macquarie identifies 3 ASX shares with dividend yields over 5%
    June 2, 2026, 8:57 PM EDT. Macquarie forecasts strong dividend yields exceeding 5% from three ASX-listed companies over the next few years. APA Group (ASX: APA), a gas pipeline operator, is expected to yield 5.7% this year, rising to 5.9% by 2028, supported by stable revenues and government gas policies. EBOS Group Ltd (ASX: EBO), a healthcare products distributor, faces EBITDA challenges but benefits from a new government wholesaler agreement, with dividends predicted to climb from 5.9% to 6.9% by 2028. Nine Entertainment (ASX: NEC) could see improved advertising revenue and new digital platform payments for news, with Macquarie optimistic about a market rebound by FY27. All three offer potential income strength amid varying sector dynamics.